The Longevity Bracket: Finally Ranked

The 10 Highest-Yield Things You Can Do to Extend Your Healthspan — Ranked by the Evidence

By the Bio Precision Aging Editorial Team

Reading time: ~12 minutes

The Premise

Every year, the longevity world gets louder. From Rapamycin, GLP-1s, Epigenetic reprogramming, and Blood filtration. A single glance at the 2026 Longevity Bracket, the 64-intervention tournament assembled by longevity experts, tells you that the space has moved well past vitamins and vague wellness advice. Yet for a 63-year-old executive trying to allocate time, capital, and attention, the question is not what is new. It is what actually works.

This piece ranks the ten interventions with the strongest, most durable evidence for extending the years you live well. Every item below is grounded in peer-reviewed data, large prospective cohorts, randomized controlled trials, and published meta-analyses, and every ranking is calibrated to the effect size on all-cause mortality or a closely linked composite endpoint. Experimental molecules with promising but immature human data are noted where relevant, but the top of the list belongs to interventions whose benefits are no longer seriously disputed.

The biases up front: I weigh mortality data heavily, I discount anything that survives only in rodents, and I give extra credit to interventions with large effect sizes, well-understood mechanisms, and low downsides. If you are an executive, a biohacker, or simply someone who wants to compound health the way you compound capital, this is the shortlist.

How These Were Ranked

Three criteria drove the ordering. First, the magnitude of benefit is measured against all-cause mortality or a tightly linked composite (major adverse cardiovascular events, cancer incidence, or disability-free survival). Second, quality of evidence — randomized trials and large meta-analyses outrank single cohorts, and human data always outrank animal data. Third, practicality and safety at the individual level. An intervention with a 30 percent effect that nobody can sustain is worth less than a 15 percent effect that compounds for twenty years.

The Ranking

#1  Do Not Smoke. If You Do, Quit Today.

THE SINGLE HIGHEST-YIELD DECISION IN MEDICINE

Nothing else on this list comes close to the magnitude of smoking. Pooled data from four large national cohorts covering 1.48 million adults show that current smokers carry roughly 2.7 to 2.8 times the all-cause mortality risk of never-smokers, and lose twelve to thirteen years of life between ages 40 and 79 compared to people who never smoked. Cessation before age 40 averts approximately 90 percent of the lifetime excess mortality attributable to smoking, and even short-term cessation under three years cuts the excess death risk by roughly 90 to 95 percent in younger adults. Long-term cessation of ten or more years restores survival curves to near-never-smoker levels.

The mechanism is not mysterious; chronic endothelial damage, accelerated atherosclerosis, carcinogenesis, and obstructive pulmonary disease stack on top of each other. The practical point is that the body begins recovering the moment the exposure ends. Nicotine replacement, varenicline, and behavioral support approximately triple quit rates. If you smoke, stopping is mathematically the most consequential health decision you can make this decade.

The verdict: roughly twelve to thirteen years of life expectancy on the table. There is no supplement, no protocol, and no molecule currently in trials with an effect size in this neighborhood.

#2  Build and Maintain Cardiorespiratory Fitness (VO₂ Max)

THE STRONGEST SINGLE BIOMARKER OF LONGEVITY

VO₂ max — the maximum volume of oxygen your body can consume and use during exercise — is arguably the most predictive single number in longevity medicine. An overview of 26 meta-analyses covering over 20.9 million observations found that comparing high versus low cardiorespiratory fitness yielded a hazard ratio of 0.47 for all-cause mortality, corresponding to a 53% relative risk reduction. On a dose-response basis, every one-metabolic-equivalent (MET) increase in fitness, roughly 3.5 mL/kg/min of VO₂, is associated with an 11 to 17 percent reduction in mortality risk.

The largest fitness cohort ever assembled — 750,000 U.S. veterans analyzed by Kokkinos and colleagues — confirmed that this relationship holds across age, sex, race, and comorbidity burden, and, crucially, showed no upper limit to the benefit. Comparing the least fit quintile to the top 98th percentile, twenty-year survival shifted from under 40 percent to roughly 80 percent in men. The Copenhagen Male Study found that each unit increase in VO₂ max was associated with 45 days of longevity over 46 years of follow-up, even after excluding early deaths to rule out reverse causation.

The build strategy is well characterized. Zone 2 training (conversational-pace cardio, roughly 180 minus age for heart rate), four to five hours per week, establishes mitochondrial density and capillary networks. One weekly session of high-intensity intervals — typically 4x4 minutes at near-maximal effort with 3 minutes recovery, drives VO₂ max adaptations directly. Practically, target moving from whatever your current category is into the next one up. That single category jump is worth more than almost any supplement sold.

The verdict: cardiorespiratory fitness is not optional. For executives who delegate everything else, this is the one variable worth training personally.

#3  Resistance Train — Build and Defend Muscle

THE INTERVENTION THAT DECIDES HOW YOU DIE

Two meta-analyses frame the case sharply. Shailendra and colleagues analyzed ten cohort studies and found that any amount of resistance training reduced all-cause mortality by 15 percent, cardiovascular disease mortality by 19 percent, and cancer mortality by 14 percent. A dose-response analysis identified the sweet spot at roughly 60 minutes per week, where the maximum mortality risk reduction reached 27 percent. A separate meta-analysis by Momma and colleagues covering 16 cohort studies reported a 10-17% lower risk of all-cause mortality, cardiovascular disease, cancer, and diabetes, with the peak benefit at 30-60 minutes per week.

The numbers reveal something counterintuitive: the optimal mortality dose is not hours per day but roughly two thirty-minute sessions per week. The leverage comes from what muscle mass and strength prevent — sarcopenia, falls, fractures, insulin resistance, and the cascade of frailty that determines whether the last decade of life is active. When aerobic exercise and resistance training are combined, the hazard ratios compound. Meeting both guidelines in adults with hypertension, for example, produced the lowest mortality risk in every subgroup studied.

Prioritize compound movements, squat, hinge, push, pull, carry, progressively loaded. For adults over fifty, the 2026 American College of Sports Medicine guidelines emphasize two to three sessions weekly, with at least one set per major muscle group taken near failure. Grip strength and leg power are two of the most robust independent predictors of mortality in older adults, and both respond to deliberate training at any age.

#4  Optimize Blood Pressure Aggressively

THE CHEAPEST, HIGHEST-YIELD MEDICAL INTERVENTION YOU CAN MAKE

The SPRINT trial randomized 9,361 adults at elevated cardiovascular risk to an intensive systolic target of under 120 mm Hg versus a standard target of under 140 mm Hg. The intensive group achieved a mean systolic of 121.4 mm Hg versus 136.2 mm Hg, and the trial was stopped early for benefit: the primary composite of major adverse cardiovascular events dropped by 25 percent, and all-cause mortality fell by 27 percent — a number needed to treat of 83 over just 3.3 years. The final SPRINT report, pooling intervention and post-trial follow-up, confirmed that targeting below 120 mm Hg produced lower major adverse event rates and lower all-cause mortality than a target below 140 mm Hg.

The nuance: benefits in older adults over 60 are concentrated in stroke prevention and major adverse cardiovascular events rather than all-cause mortality in every meta-analytic dataset, and a subgroup with baseline systolic over 160 and lower Framingham risk showed harm with aggressive lowering. Translation: the right target is individualized, but for most adults at elevated cardiovascular risk, pushing toward 120 is supported by the strongest randomized evidence in the field.

In practice, buy a validated home monitor, measure twice daily for a week each quarter, and build your average. If you are persistently above 130, get on a regimen, lifestyle plus pharmacology where needed. Modern agents are cheap, generic, and tolerated well.

#5  Eat a Mediterranean-Pattern Diet

THE ONLY DIETARY PATTERN WITH LANDMARK RCT EVIDENCE

The Mediterranean diet is the only dietary pattern with randomized controlled trial evidence for hard cardiovascular endpoints. The 2024 Women's Health Study analysis followed 25,315 women for 25 years and found that greater adherence was associated with a 23% reduction in all-cause mortality. A 2024 meta-analysis of randomized trials including PREDIMED and CORDIOPREV found a 48 percent reduction in major adverse cardiovascular events, a 38 percent reduction in myocardial infarction, a 37 percent reduction in stroke, and a 46 percent reduction in cardiovascular death. A meta-analysis of over 1.7 million participants found lower risk of all-cause mortality, breast cancer, multiple gastrointestinal cancers, head and neck cancer, and prostate cancer with higher adherence.

The pattern is prosaic: extra-virgin olive oil as the primary fat, vegetables and legumes at most meals, fish several times per week, nuts daily, whole grains, moderate poultry and dairy, minimal red and processed meat, and red wine only with meals if consumed at all. The biomarker fingerprint is consistent: lower C-reactive protein, lower oxidized LDL, better insulin sensitivity, and improved endothelial function.

What the evidence does not support: elaborate elimination diets, carnivore protocols, or extended fasting regimens as primary longevity strategies. They may have niche applications, but the mortality data does not.

#6  Sleep Seven to Eight Hours, Consistently

THE NON-NEGOTIABLE INFRASTRUCTURE

Sleep duration and mortality follow a U-shaped curve. A 2025 meta-analysis in GeroScience found that short sleep of fewer than 7 hours increased mortality risk by 14 percent, while long sleep of 9 hours or more increased it by 34 percent. A large dose-response meta-analysis of prospective cohort studies published in the Journal of the American Heart Association confirmed the nadir of risk at approximately seven hours per night, with each hour below seven raising mortality risk by 6 percent and each hour above seven raising it by 13 percent.

Sleep regularity, the day-to-day consistency of bedtime and wake time, may matter as much as duration. A 2024 UK Biobank analysis of over 60,000 adults using accelerometer data found that sleep regularity was a stronger predictor of all-cause, cardiovascular, and cancer mortality than total duration. The implication: the executive who sleeps seven hours Monday through Friday and twelve on weekends is not actually rested.

The levers are boring but effective. Fixed wake time seven days a week. Morning sunlight exposure within thirty minutes of waking. Bedroom at 65 to 68 degrees. No alcohol within three hours of bed. For adults over fifty with snoring or daytime fatigue, a sleep study to rule out obstructive sleep apnea is one of the highest-yield diagnostic investments available. Untreated sleep apnea is a major amplifier of every other cardiovascular risk factor on this list.

#7  Invest in Social Connection

THE HEALTH INTERVENTION MEDICINE KEEPS UNDERWEIGHTING

Holt-Lunstad and colleagues at Brigham Young University have produced the definitive body of work here. Their 2010 meta-analysis of 148 studies involving over 300,000 participants found that strong social relationships were associated with a 50% increase in the odds of survival. Their 2015 follow-up, covering more than 3.4 million individuals, quantified the downside: social isolation increased mortality risk by 29 percent, loneliness by 26 percent, and living alone by 32 percent. The effect size is comparable to smoking and larger than obesity.

The mechanisms are biological, not just psychological. Chronic loneliness elevates systemic inflammation, dysregulates hypothalamic-pituitary-adrenal axis cortisol patterns, impairs immune function, and alters cardiovascular regulation. These are not soft endpoints — they are the same pathways implicated in atherosclerosis and cancer progression.

The intervention is less intuitive than a training protocol. Build weekly ritual contact with three to five people who know you well. Preserve legacy friendships; they are harder to replace as the decades pass. For executives whose work has eroded personal networks, this is a rebuild worth scheduling the way you would schedule a board meeting. It is not optional.

#8  Control Visceral Adiposity

THE NUMBER YOUR SCALE IS NOT TELLING YOU

Body mass index is an imperfect proxy for the fat that actually matters. Visceral adipose tissue — the metabolically active fat packed around abdominal organs — is what drives insulin resistance, chronic inflammation, and cardiovascular risk. A 16.9-year follow-up study found that elevated visceral fat was independently associated with a 39 percent increase in all-cause mortality and a 39 percent increase in obesity-related mortality, with waist circumference mediating the relationship.

The waist-to-height ratio is the simplest, most reliable proxy and should remain below 0.5 for most adults. Pooled analyses of over 650,000 adults confirm that each five-centimeter increase in waist circumference is associated with a 7 percent increase in all-cause mortality in men and 9 percent in women, independent of body mass index.

The levers: protein intake of roughly 1.2 to 1.6 grams per kilogram of body weight daily to preserve lean mass during any weight loss, resistance training (see #3), Zone 2 cardio (see #2), and elimination of ultra-processed foods, which drive both caloric overconsumption and visceral deposition. GLP-1 receptor agonists have emerged as a legitimate option for adults who have failed lifestyle intervention, producing 15 to 20 percent body weight reduction with meaningful cardiovascular benefit in recent trials.

#9  Stay Engaged with Proactive Medical Care

THE PREVENTABLE DEATHS YOU HAVE NOT PREVENTED YET

This category captures what the bracket calls Proactive Healthcare, the unglamorous but decisive work of catching treatable disease early and modifying risk factors before they become events. The specific items matter: age-appropriate cancer screening (colonoscopy beginning at 45, low-dose CT for lung cancer in smokers, mammography, prostate cancer screening with shared decision-making), annual comprehensive metabolic and lipid panels, ApoB or lipoprotein(a) at least once, and coronary artery calcium scoring in the fifth or sixth decade for anyone with risk factors.

For primary prevention of atherosclerotic cardiovascular disease, the 2026 American College of Cardiology and American Heart Association guidelines emphasize early and aggressive LDL-C reduction in elevated-risk adults, and statin therapy remains one of the most robustly supported pharmacologic interventions in medicine. PCSK9 inhibitors have added a meaningful additional reduction for those who need it. Vaccination, including the shingles vaccine after age 50, annual influenza, and respiratory syncytial virus in older adults, has clear evidence for mortality and morbidity reduction.

The common failure mode among high-functioning executives is assuming they will feel the warning signs. Most of the conditions that kill adults between 50 and 75, atherosclerotic cardiovascular disease, type 2 diabetes, and many cancers, are asymptomatic until they are not. Screening and proactive management are the margin.

#10  Maintain Oral Health

THE UNLIKELIEST LONGEVITY INTERVENTION

Oral health appearing this high on any serious longevity ranking surprises most readers. It should not. Periodontal disease has been associated in multiple large cohorts with 15 to 25 percent increases in cardiovascular disease risk, and oral bacteria, including Porphyromonas gingivalis, have been identified in atherosclerotic plaques and in the brains of Alzheimer's disease patients. The chronic low-grade bacteremia from inflamed gums appears to meaningfully amplify systemic inflammation, which is the thread connecting cardiovascular, metabolic, and neurodegenerative disease.

The protocol is routine: twice-daily brushing, daily flossing or water flossing, professional cleaning every six months, and prompt treatment of periodontal disease. The effect size per unit effort makes this one of the most leveraged items on this list.

Honorable Mentions

Several bracket interventions warrant mention but did not make the top ten either because the human evidence is still immature or because the effect sizes do not yet rival those above.

Caloric Restriction and Time-Restricted Eating

The CALERIE-2 trial randomized 220 healthy non-obese adults to two years of 25 percent caloric restriction versus ad libitum. The intervention achieved an average of 11.9 percent restriction and produced measurable slowing of biological aging as assessed by the DunedinPACE epigenetic clock, along with improvements in cardiometabolic risk factors, inflammatory biomarkers, and senescence-associated secretory phenotype proteins. The data are the strongest human randomized evidence for a broad anti-aging intervention, but mortality endpoints remain unstudied at scale, and sustainability at a 25 percent restriction is a genuine question for most adults.

Rapamycin

Rapamycin remains the single most compelling pharmacologic candidate for lifespan extension based on animal data. Mouse trials conducted by the Interventions Testing Program have shown consistent lifespan extension at multiple doses and ages. Human trials to date are small, short-duration, and focused on immune biomarkers and age-related pathology rather than mortality. Off-label use is a defensible position for informed adults working with a longevity-literate physician, but the evidence is not yet mature enough to place it above interventions with decades of mortality data.

Acarbose, Metformin, GLP-1 Agonists

All three modulate glucose and weight. Acarbose has strong rodent longevity data. Metformin's effect on human longevity remains ambiguous following the MILES and TAME trials, and it may blunt training adaptations in non-diabetic adults. GLP-1 agonists have the clearest modern cardiovascular and weight evidence, and increasingly look like a metabolic health intervention that happens to have longevity-adjacent effects.

Sauna, Cold Exposure, Zone 2 HIIT

Sauna use has Finnish cohort data supporting 40 percent reductions in cardiovascular mortality at four to seven sessions weekly. These are observational associations, not randomized evidence, and the confounding with general health and affluence is real. The protocols are low-cost and low-risk, so they warrant inclusion in a broader stack — they simply do not have the evidentiary weight of the top ten.

Putting It Together: The Executive Stack

Reading a list of 10 items rarely leads to action. The integrated protocol below consolidates the evidence into a weekly cadence that compounds across all ten categories.

Weekly Training

Three to four Zone 2 cardio sessions of 45 to 60 minutes each. One high-intensity interval session. Two to three resistance training sessions emphasizing compound lifts. Target: eight to ten hours of total training per week. This single block addresses items #2, #3, and #8 simultaneously.

Daily Nutrition

Mediterranean pattern as the default. Extra-virgin olive oil as primary cooking fat. Protein intake targeted at 1.2 to 1.6 grams per kilogram of body weight. Ultra-processed foods are minimized. Alcohol was moderated or eliminated. Eating window of roughly 10 to 12 hours, where feasible.

Sleep Architecture

Fixed wake time. Seven to eight hours of sleep. Morning sunlight exposure. Temperature-controlled bedroom. Sleep apnea ruled out if any risk factors. This is the cheapest, most consequential piece of infrastructure in the stack.

Quarterly and Annual Medical

Annual comprehensive panel including ApoB, lipoprotein(a) at least once, HbA1c, hsCRP, vitamin D, and a comprehensive metabolic panel. Home blood pressure averages. Coronary artery calcium score in the fifth decade. Age-appropriate cancer screening on schedule. Dental cleaning every six months.

Relational Infrastructure

Weekly structured contact with three to five close people. Monthly contact with a broader circle of ten to fifteen. Annual retreats or trips that reinforce long-standing friendships. This is the item executives most often underfund.

The Bottom Line

The 2026 Longevity Bracket is a useful map of what people are excited about. It is not a ranking of what works. The ten items above are what work, measured against hard endpoints in real populations, over years to decades. None of them requires a clinic, a biotech portfolio, or a molecule still in phase two trials. Nine of the ten are free or near-free. Eight of the ten compound with each other.

If you are a 45-year-old executive reading this, the asymmetry is extraordinary. The downside of executing the top five items is marginal — some training time, some dietary discipline, some sleep hygiene. The upside is a structurally different last three decades of life. The actuarial tables were written for people who did not do any of this. You are not obligated to be in them.

Average is not the target.

— W.L.

MEDICAL DISCLAIMER

This article is for educational and informational purposes only and does not constitute medical advice. The content is not intended to diagnose, treat, cure, or prevent any disease, and is not a substitute for consultation with a qualified, licensed healthcare provider. Individual risk factors, medical history, current medications, and comorbid conditions materially affect the appropriateness of any intervention discussed. Always consult your physician or other qualified healthcare professional before beginning any new diet, exercise, supplement, or pharmacologic regimen. Bio Precision Aging and its contributors assume no liability for any adverse outcomes arising from the application of the information contained herein.

Key References

• Thomson B, et al. Smoking Cessation and Short- and Longer-Term Mortality. NEJM Evidence. 2024; EVIDoa2300272.

• Shailendra P, et al. Resistance Training and Mortality Risk: A Systematic Review and Meta-Analysis. Am J Prev Med. 2022;63(2):277-285.

• Momma H, et al. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis. Br J Sports Med. 2022;56(13):755-763.

• Lang JJ, et al. Cardiorespiratory fitness is a strong and consistent predictor of morbidity and mortality among adults: an overview of meta-analyses representing over 20.9 million observations from 199 unique cohort studies. Br J Sports Med. 2024;58:556-566.

• Kokkinos P, et al. Cardiorespiratory Fitness and Mortality Risk Across the Spectra of Age, Race, and Sex. J Am Coll Cardiol. 2022;80(6):598-609.

• SPRINT Research Group. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2021;384(20):1921-1930.

• Ahmad S, et al. Mediterranean Diet Adherence and Risk of All-Cause Mortality in Women. JAMA Netw Open. 2024;7(5):e2414322.

• Sebastian SA, et al. Long-term impact of Mediterranean diet on cardiovascular disease prevention: A systematic review and meta-analysis of RCTs. Curr Probl Cardiol. 2024;49(5):102509.

• Pacifico A, et al. Imbalanced sleep increases mortality risk by 14–34%: a meta-analysis. GeroScience. 2025.

• Yin J, et al. Relationship of Sleep Duration With All-Cause Mortality and Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis. J Am Heart Assoc. 2017;6:e005947.

• Windred DP, et al. Sleep regularity is a stronger predictor of mortality risk than sleep duration. SLEEP. 2024;47(1):zsad253.

• Holt-Lunstad J, et al. Social Relationships and Mortality Risk: A Meta-analytic Review. PLoS Med. 2010;7(7):e1000316.

• Holt-Lunstad J, et al. Loneliness and Social Isolation as Risk Factors for Mortality: A Meta-Analytic Review. Perspect Psychol Sci. 2015;10(2):227-237.

• Waziry R, et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nat Aging. 2023;3:248-257.

• Cerhan JR, et al. A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc. 2014;89(3):335-345.